The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The growing role of nanotechnology in combating infectious disease
Open accessAbstract
The treatment and prevention of infectious diseases is a major part of both clinical and investigative medicine. As the use of conventional antibiotics rises, antimicrobial resistance patterns develop, necessitating the continuous need for newer and more effective therapies. Nanotechnology, defined as the production and application of materials in the nanoscale range (1-100 nm), has been the focus of several investigations as a result of unique physical and chemical properties of nanomaterials. . Specifically, nanomaterials provide added benefits due to their small size; allowing for an increased ability to surpass most physiologic barriers and reach their intended targets, and high surface area-to-volume ratio, allowing for increased potential to interact with pathogen membranes and cell walls. This review focuses of the potential therapeutic and preventative applications of nanotechnology-based drug delivery systems in infectious disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Characterization of enhanced antibacterial effects of novel silver nanoparticles
Shrivastava, S., Bera, T., Roy, A., Singh, G., Ramachandrarao, P., & Dash, D. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/22/225103 · Cited by 1,523
RetractedSilver nanoparticles as a new generation of antimicrobials
Rai, M., Yadav, A., & Gade, A. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.09.002 · Cited by 6,173
Antimicrobial effects of silver nanoparticles
Kim, J. S., Kuk, E., Yu, K. N., Kim, J.-H., Park, S. J., Lee, H. J., Kim, S. H., Park, Y. K., Park, Y. H., Hwang, C.-Y., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.001 · Cited by 4,918
Pal, S., Tak, Y. K., & Song, J. M. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02218-06 · Cited by 4,040
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Metal Oxide Nanoparticles as Bactericidal Agents
Stoimenov, P. K., Klinger, R. L., Marchin, G. L., & Klabunde, K. J. (2002) · Langmuir · doi:10.1021/la0202374 · Cited by 1,887
Strain specificity in antimicrobial activity of silver and copper nanoparticles
Ruparelia, J. P., Chatterjee, A. K., Duttagupta, S. P., & Mukherji, S. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2007.11.006 · Cited by 1,885
Preparation and antibacterial activity of chitosan nanoparticles
Qi, L., Xu, Z., Jiang, X., Hu, C., & Zou, X. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2004.09.007 · Cited by 1,804
Characterisation of copper oxide nanoparticles for antimicrobial applications
Ren, G., Hu, D., Cheng, E. W. C., Vargas-Reus, M. A., Reip, P., & Allaker, R. P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.12.004 · Cited by 1,604
Shahverdi, A. R., Fakhimi, A., Shahverdi, H. R., & Minaian, S. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.02.001 · Cited by 1,299
Liu, Y., He, L., Mustapha, A., Li, H., Hu, Z. Q., & Lin, M. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04303.x · Cited by 892
Copper Nanoparticle/Polymer Composites with Antifungal and Bacteriostatic Properties
Cioffi, N., Torsi, L., Ditaranto, N., Tantillo, G., Ghibelli, L., Sabbatini, L., Bleve-Zacheo, T., D'Alessio, M., Zambonin, P. G., & Traversa, E. (2005) · Chemistry of Materials · doi:10.1021/cm0505244 · Cited by 834
Martinez-Gutierrez, F., Olive, P. L., Banuelos, A., Orrantia, E., Nino, N., Sanchez, E. M., Ruiz, F., Bach, H., & Av-Gay, Y. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.02.001 · Cited by 497
Jin, T., Sun, D., Su, J. Y., Zhang, H., & Sue, H. ‐. (2009) · Journal of Food Science · doi:10.1111/j.1750-3841.2008.01013.x · Cited by 488
Kwak, S.-Y., Kim, S. H., & Kim, S. S. (2001) · Environmental Science & Technology · doi:10.1021/es0017099 · Cited by 461
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications
Pinto-Alphandary, H., Andremont, A., & Couvreur, P. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00121-1 · Cited by 428
The antibacterial properties of a novel chitosan–Ag-nanoparticle composite
Sanpui, P., Murugadoss, A., Prasad, P. V. D., Ghosh, S. S., & Chattopadhyay, A. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.03.004 · Cited by 397
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Tolentino, M. (2011) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2010.08.006 · Cited by 304
Liu, L., Zhong, Q., Tian, T., Dubin, K., Athale, S. K., & Kupper, T. S. (2010) · Nature Medicine · doi:10.1038/nm.2078 · Cited by 252
Martinez, L. R., Han, G., Chacko, M., Mihu, M. R., Jacobson, M., Gialanella, P., Friedman, A. J., Nosanchuk, J. D., & Friedman, J. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.95 · Cited by 244
Self-citationViral nanoparticles and virus‐like particles: platforms for contemporary vaccine design
Plummer, E. M., & Manchester, M. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.119 · Cited by 237
Sun, H.-X., Xie, Y., & Ye, Y.-P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.032 · Cited by 235
Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles
Dillen, K., Vandervoort, J., Van den Mooter, G., & Ludwig, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.041 · Cited by 230
Friedman, A. J., Han, G., Navati, M. S., Chacko, M., Gunther, L., Alfieri, A., & Friedman, J. M. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.003 · Cited by 220
Self-citationSynergistic antibacterial activity of chitosan–silver nanocomposites on Staphylococcus aureus
Potara, M., Jakab, E., Damert, A., Popescu, O., Canpean, V., & Astilean, S. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/13/135101 · Cited by 203
Nanotechnology solutions for mucosal immunization
Chadwick, S., Kriegel, C., & Amiji, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.012 · Cited by 203
Banerjee, M., Mallick, S., Paul, A., Chattopadhyay, A., & Ghosh, S. S. (2010) · Langmuir · doi:10.1021/la9038528 · Cited by 196
Brunner, C., Seiderer, J., Schlamp, A., Bidlingmaier, M., Eigler, A., Haimerl, W., Lehr, H.-A., Krieg, A. M., Hartmann, G., & Endres, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6278 · Cited by 192
Antibiofilm activity of nanosized magnesium fluoride
Lellouche, J., Kahana, E., Elias, S., Gedanken, A., & Banin, E. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.037 · Cited by 166
Regulating Immune Response Using Polyvalent Nucleic Acid−Gold Nanoparticle Conjugates
Massich, M. D., Giljohann, D. A., Seferos, D. S., Ludlow, L. E., Horvath, C. M., & Mirkin, C. A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900172m · Cited by 163
Mohammadi, G., Valizadeh, H., Barzegar-Jalali, M., Lotfipour, F., Adibkia, K., Milani, M., Azhdarzadeh, M., Kiafar, F., & Nokhodchi, A. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2010.05.027 · Cited by 161
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Makidon, P. E., Bielinska, A. U., Nigavekar, S. S., Janczak, K. W., Knowlton, J., Scott, A. J., Mank, N., Cao, Z., Rathinavelu, S., Beer, M. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002954 · Cited by 159
Homogeneous Conjugation of Peptides onto Gold Nanoparticles Enhances Macrophage Response
Bastús, N. G., Sànchez‐Tilló, E., Pujals, S., Farrera, C., López‐Iglesias, C., Giralt, E., Celada, A., Lloberas, J., & Puntes, V. (2009) · ACS Nano · doi:10.1021/nn8008273 · Cited by 157
Mahé, B., Vogt, A., Liard, C., Duffy, D., Abadie, V., Bonduelle, O., Boissonnas, A., Sterry, W., Verrier, B., Blume‐Peytavi, U., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.356 · Cited by 140
Han, G., Martinez, L. R., Mihu, M. R., Friedman, A., Friedman, J. M., & Nosanchuk, J. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007804 · Cited by 135
Self-citationPLGA: Poloxamer and PLGA: Poloxamine blend nanostructures as carriers for nasal gene delivery
Csaba, N., Sánchez, A., & Alonso, M. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.017 · Cited by 120
Preparation of chitosan–nylon-6 blended membranes containing silver ions as antibacterial materials
Ma, Y., Zhou, T., & Zhao, C. (2007) · Carbohydrate Research · doi:10.1016/j.carres.2007.11.006 · Cited by 119
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
Ghosh, S., Kaushik, R., Nagalakshmi, K. V., Hoti, S. L., Menezes, G. A., Harish, B. N., & Vasan, H. N. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.08.001 · Cited by 118
Semete, B., Booysen, L. I. J., Kalombo, L., Venter, J. D., Katata, L., Ramalapa, B., Verschoor, J. A., & Swai, H. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.002 · Cited by 108
Combadière, B., Vogt, A., Mahé, B., Costagliola, D. G., Hadam, S., Bonduelle, O., Sterry, W., Staszewski, S., Schaefer, H. E., van der Werf, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010818 · Cited by 107
Bal, S. M., Slütter, B., van Riet, E., Kruithof, A. C., Ding, Z., Kersten, G. F. A., Jiskoot, W., & Bouwstra, J. A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.018 · Cited by 89
Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS
Maloy, K. J., Donachie, A. M., & Mowat, A. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251019 · Cited by 87
Vieira, D. B., & Carmona‐Ribeiro, A. M. (2008) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-6-6 · Cited by 70
Immunogenic Properties of Colloidal Gold
Dykman, L. A., Sumaroka, M. V., Staroverov, S. A., Zaitseva, I. S., & Bogatyrev, V. A. (2004) · Biology Bulletin · doi:10.1023/b:bibu.0000014358.98422.9c · Cited by 67
Muttil, P., Prego, C., Garcia‐Contreras, L., Pulliam, B., Fallon, J. K., Wang, C., Hickey, A. J., & Edwards, D. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9192-2 · Cited by 66
Rajananthanan, P., Attard, G. S., Sheikh, N. A., & Morrow, W. J. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00256-4 · Cited by 62
Fontana, G., Pitarresi, G. L., Tomarchio, V., Carlisi, B., & Biagio, P. L. S. (1998) · Biomaterials · doi:10.1016/s0142-9612(97)00246-9 · Cited by 59
A Novel, Killed-Virus Nasal Vaccinia Virus Vaccine
Bielinska, A. U., Чепурнов, А. А., Landers, J. J., Janczak, K. W., Chepurnova, T. S., Luker, G. D., & Baker, J. R. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00440-07 · Cited by 50
Wu, Y., Jia, W., An, Q., Liu, Y., Chen, J., & Li, G. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/24/245101 · Cited by 43
Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases
Moore, M. D., Cookson, J., Coventry, V. K., Sproat, B. S., Rabe, L. K., Cranston, R., McGowan, I., & James, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178426 · Cited by 37
Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics.
Price, C. I., Horton, J. W., & Baxter, C. R. (1994) · PubMed · Cited by 29
Englander, L., & Friedman, A. (2010) · PubMed Central · Cited by 28
Self-citationFrom bench to bedside: the therapeutic potential of nitric oxide in dermatology.
Han, G., Zippin, J. H., & Friedman, A. (2009) · PubMed · Cited by 12
Self-citation
Cited by
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Self-citationAlternative Antimicrobial Approach: Nano-Antimicrobial Materials
Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., & Hazan, R. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/246012 · Cited by 837
Nanobio Silver: Its Interactions with Peptides and Bacteria, and Its Uses in Medicine
Eckhardt, S., Brunetto, P. S., Gagnon, J., Priebe, M., Giese, B., & Fromm, K. M. (2013) · Chemical Reviews · doi:10.1021/cr300288v · Cited by 794
Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field
Yu, Z., Li, Q., Wang, J., Yu, Y., Wang, Y., Zhou, Q., & Li, P. (2020) · Nanoscale Research Letters · doi:10.1186/s11671-020-03344-7 · Cited by 709
Pure and multi metal oxide nanoparticles: synthesis, antibacterial and cytotoxic properties
Stankic, S., Suman, S., Haque, F., & Vidic, J. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0225-6 · Cited by 678
Metadata
- Authors
- Blecher, K., Nasir, A., & Friedman, A.
- Venue
- Virulence
- Publisher
- Informa UK Limited
- Published
- 2011-09
- Volume
- 2
- Issue
- 5
- Pages
- 395-401
- ISSN
- 2150-5594 (ISSN-L)
- 2150-5608
- OpenAlex
- W2045878828
- Cited by
- 345
- References
- 54
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.